Category: Candy, confectionary, snacks and sweeteners
What to do: Do not consume recalled products to which you are allergic or sensitive.
Audience: General public
Recall class: Class 1
Affected products
Brand
Product
Size
UPC
Codes
Crave Stevia
Almond All Natural Chocolate
80 g
85 g
8 84063 00088 3
All codes where milk is not declared on the label
Crave Stevia
Dark All Natural Chocolate
80 g
85 g
8 84063 00085 2
All codes where milk is not declared on the label
Crave Stevia
Mint All Natural Chocolate
80 g
85 g
8 84063 00084 5
All codes where milk is not declared on the label
Crave Stevia
Sea Salt All Natural Chocolate
80 g
85 g
8 84063 00083 8
All codes where milk is not declared on the label
Crave Stevia
Sprinkles All Natural Chocolate
80 g
85 g
8 84063 00118 7
All codes where milk is not declared on the label
Crave Stevia
Chocolate Chips
200 g
8 84063 00069 2
All codes where milk is not declared on the label
Issue
The affected products are being recalled from the marketplace because they may contain milk which is not declared on the label.
The recalled products have been sold in British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, Quebec, New Brunswick, and Nova Scotia, and may have been distributed in other provinces and territories. They have also been sold online.
What you should do
Check to see if you have recalled products
Do not consume recalled products to which you are allergic or sensitive as they may cause a serious or life-threatening reaction
Do not serve, use, sell or distribute recalled products
Recalled products should be thrown out or returned to the location where they were purchased
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community. Aspire Health experienced a data security incident that may have involved personal and...